Kin Man Au

Research Assistant Professor

University of Texas Southwestern Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Kin Man Au is a Research Assistant Professor at The University of Texas Southwestern Medical Center in the United States. His research focuses on innovative immunotherapy strategies, including biologically targeted approaches for cancer treatment and immune modulation in autoimmune diseases. Recent publications highlight his contributions to developing treatments for conditions such as clear cell renal cell carcinoma, multiple sclerosis, and early-onset Type 1 diabetes mellitus.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (1)

Andrew Wang

Professor with Tenure, A.Kenneth Pye Professorship in Cancer Research, Vice Chair of Research

University of Texas Southwestern Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kin Man Au

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Multiple sclerosis treatments a review of current biomedical engineering approaches

Biologically targeted dual adaptive and innate nano-Immunotherapy for clear cell renal cell carcinoma treatment

Intratumoral Injectable Redox‐Responsive Immune Niche Improves the Abscopal Effect in Radiotherapy

An injectable subcutaneous colon-specific immune niche for the treatment of ulcerative colitis

Immune Checkpoint Ligand Bioengineered Schwann Cells as Antigen‐Specific Therapy for Experimental Autoimmune Encephalomyelitis

In Vivo Bioengineering of Beta Cells with Immune Checkpoint Ligand as a Treatment for Early-Onset Type 1 Diabetes Mellitus

Immune Checkpoint‐Bioengineered Beta Cell Vaccine Reverses Early‐Onset Type 1 Diabetes

Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer models.

Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy

Pretargeted delivery of PI3K/mTOR small-molecule inhibitor–loaded nanoparticles for treatment of non-Hodgkin’s lymphoma

Collaborators (1)

Andrew Wang

Make your next move.